Trial Search Results

Biopsy of Human Tumors for Cancer Stem Cell Characterization: a Feasibility Study

To see if a limited sampling of tumor tissue from human subjects is a feasible way to gather adequate tissue for cancer stem cell quantification.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Intervention(s):

  • Procedure: tumor biopsy

Eligibility


Inclusion Criteria:1. Patients with malignant tumors seen at the Stanford University Cancer
Center. Eligible patients will have a diagnosis of squamous cell carcinoma (HNSCC) and will
have been seen in the Stanford Head and Neck Oncology Program. A decision to undergo
surgery at Stanford will have been made, prior to recruiting patients for the study, and
prior to obtaining the samples during surgery. (Histological confirmation of the diagnosis
need not be made prior to obtaining consent.) 2. A definitive resection of a malignant
tumor is planned. 3. Surgeon judgment that the definitive procedure will not be compromised
by including

   - FNA

   - Core needle biopsy

   - Cup forceps or punch biopsy of<4mm. 4. Informed consent documented prior to procedure

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study

All

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
ccto-office@stanford.edu
650-498-7061